Turkish Journal of Nephrology
Original Article

Current Status of Renal Replacement Therapies in Turkey: Turkish Society of Nephrology Registry 2015 Summary Report

1.

İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye

2.

Ankara Üniversitesi, Ankara Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Ankara, Türkiye

3.

Akdeniz Üniversitesi, Akdeniz Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Antalya, Türkiye

Turkish J Nephrol 2017; 26: 154-160
DOI: 10.5262/tndt.2017.1002.04
Read: 742 Downloads: 182 Published: 31 January 2019

OBJECTIVE: The Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on an annual basis. Registry reports are printed every year as a booklet and this is the 26th year of registry reports. The registry is in close collaboration with international registries.

MATERIAL and METHODS: In this paper, data from the 2015 registry report are summarized and additionally yearly trends in the management of end-stage renal disease are provided.

RESULTS: The number of patients on renal replacement therapy is increasing with 73660 patients on renal replacement therapy at the end of 2015. The prevalence and incidence of end-stage renal disease was 935 and 147 per million population respectively. Diabetes mellitus was the most important cause of end-stage renal disease. Hemodialysis (77.3%) was the most common type of treatment modality, followed by transplantation (17.4%) and peritoneal dialysis (5.3%).

CONCLUSION: End-stage kidney disease is a very important and growing health problem for our country. The renal registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem.

Files
EISSN 2667-4440